Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 5/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | PPP5C | P53041 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20797138 | 0.85 | GBA1 (0.42) | ADRB2ADRB1ADRB3GBA1SMN1; SMN2 | |
| SCHEMBL20787027 | 0.82 | — | — | |
| SCHEMBL20787021 | 0.72 | ALDH1A1 (0.33) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL16711496 | 0.70 | GBA1 (0.38) | ADRB2ADRB1ADRB3GBA1SMN1; SMN2 | |
| SCHEMBL11790150 | 0.69 | GBA1 (0.50) | ADRB2ADRB1ADRB3GBA1SMN1; SMN2 | |
| SCHEMBL20797171 | 0.69 | GBA1 (0.31) | GBA1 | |
| SCHEMBL6518428 | 0.67 | GBA1 (0.43) | ADRB2ADRB1ADRB3GBA1SMN1; SMN2 | |
| SCHEMBL6362337 | 0.67 | SMN1; SMN2 (0.43) | ADRB2ADRB1ADRB3GBA1SMN1; SMN2 | |
| SCHEMBL5986706 | 0.67 | — | — | |
| SCHEMBL9500810 | 0.67 | ADRB2 (0.39) | ADRB2ADRB1ADRB3GBA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3679115-B1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2025-04-02 | — | — | EP | disclosed |
| US-20210061751-A1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-03-04 | — | — | US | disclosed |
| US-20210061751-A1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-03-04 | — | — | US | disclosed |
| EP-3679115-A1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-07-15 | — | — | EP | disclosed |
| CN-111051483-A | Esters and ethers of 2,2,4, 4-tetramethylcyclobutane-1, 3-diol as fragrance chemicals | 巴斯夫欧洲公司 | 2020-04-21 | — | — | CN | disclosed |
| WO-2019048544-A1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2019-03-14 | — | — | WO | disclosed |
| WO-2019048544-A1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2019-03-14 | — | — | WO | disclosed |
| EP-3453750-A1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2019-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061751-A1 | ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS | C9, DEGS1, CYP1A1 | ADRB2 419/4885ADRB1 451/4885ADRB3 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.